Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Annals of the Rheumatic Diseases
|
July 6, 2019
Response to: 'Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndrome' by van den Hoogen <i>et al</i>
Mariana J Kaplan, Kerry A Casey
Journal of Immunology (Baltimore, Md. : 1950)
|
June 6, 2007
IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype
Kerry A Casey, Matthew F Mescher
Journal of Immunology (Baltimore, Md. : 1950)
|
June 21, 2008
Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses
Michael Y Gerner, Kerry A Casey, Matthew F Mescher
The Journal of Experimental Medicine
|
August 30, 2017
Dendritic cell and antigen dispersal landscapes regulate T cell immunity
Michael Y Gerner, Kerry A Casey, Wolfgang Kastenmuller, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 24, 2009
Programming for CD8 T cell memory development requires IL-12 or type I IFN
Zhengguo Xiao, Kerry A Casey, Stephen C Jameson, et al.
Nature
|
November 14, 2008
Memory CD8 T-cell compartment grows in size with immunological experience
Vaiva Vezys, Andrew Yates, Kerry A Casey, et al.
Seminars in Immunology
|
March 27, 2007
Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation
Matthew F Mescher, Pujya Agarwal, Kerry A Casey, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 23, 2016
IL-15-Independent Maintenance of Tissue-Resident and Boosted Effector Memory CD8 T Cells
Jason M Schenkel, Kathryn A Fraser, Kerry A Casey, et al.
Immunological Reviews
|
July 11, 2006
Signals required for programming effector and memory development by CD8+ T cells
Matthew F Mescher, Julie M Curtsinger, Pujya Agarwal, et al.
Lupus Science & Medicine
|
December 13, 2018
Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE
Kerry A Casey, Xiang Guo, Michael A Smith, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Annals of the Rheumatic Diseases
|
July 6, 2019
Response to: 'Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndrome' by van den Hoogen <i>et al</i>
Mariana J Kaplan, Kerry A Casey
Journal of Immunology (Baltimore, Md. : 1950)
|
June 6, 2007
IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype
Kerry A Casey, Matthew F Mescher
Journal of Immunology (Baltimore, Md. : 1950)
|
June 21, 2008
Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses
Michael Y Gerner, Kerry A Casey, Matthew F Mescher
The Journal of Experimental Medicine
|
August 30, 2017
Dendritic cell and antigen dispersal landscapes regulate T cell immunity
Michael Y Gerner, Kerry A Casey, Wolfgang Kastenmuller, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 24, 2009
Programming for CD8 T cell memory development requires IL-12 or type I IFN
Zhengguo Xiao, Kerry A Casey, Stephen C Jameson, et al.
Nature
|
November 14, 2008
Memory CD8 T-cell compartment grows in size with immunological experience
Vaiva Vezys, Andrew Yates, Kerry A Casey, et al.
Seminars in Immunology
|
March 27, 2007
Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation
Matthew F Mescher, Pujya Agarwal, Kerry A Casey, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 23, 2016
IL-15-Independent Maintenance of Tissue-Resident and Boosted Effector Memory CD8 T Cells
Jason M Schenkel, Kathryn A Fraser, Kerry A Casey, et al.
Immunological Reviews
|
July 11, 2006
Signals required for programming effector and memory development by CD8+ T cells
Matthew F Mescher, Julie M Curtsinger, Pujya Agarwal, et al.
Lupus Science & Medicine
|
December 13, 2018
Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE
Kerry A Casey, Xiang Guo, Michael A Smith, et al.
Page
of 3